Stromal line . | CFC/104 BM cells ± s.e.m. . | Percentage of PWM control ± s.e.m. . | ||
---|---|---|---|---|
AM06† | 32.3±5.7 | 40.6±7.2 | ||
AM10† | 54.3±3.5 | 68.2±4.4 | ||
AM14† | 33.0±6.4 | 41.5±8.1 | ||
AM20* | 72.3±4.7 | 90.9±5.9 | ||
AM30 | 49.3±4.5 | 61.9±5.7 | ||
UG07† | 55.0±4.6 | 69.2±5.8 | ||
UG15† | 32.5±2.1 | 40.9±2.6 | ||
UG26 | 61.8±2.6 | 77.7±3.3 | ||
EL08† | 61.0±5.1 | 76.7±6.4 | ||
EL12† | 19.0±2.9 | 23.9±3.6 | ||
EL17*,† | 48.3±2.8 | 60.7±3.5 | ||
EL23 | 47.5±2.7 | 59.7±3.4 | ||
EL28 | 44.3±4.6 | 55.7±5.8 | ||
AFT024 | 35.8±2.8 | 45.0±3.5 | ||
FBMD-1 | 37.5±2.8 | 47.2±3.5 | ||
S17 | 46.8±2.1 | 58.8±2.6 | ||
Four experiments were carried out. *Stromal lines derived from E10 tissue. All other stromal lines are derived from E11 tissues. †Stromal lines derived from BL1b transgenic embryos. All other stromal lines are derived from tsA58 transgenic embryos. Culture supernatants were collected from non-irradiated cells. |
Stromal line . | CFC/104 BM cells ± s.e.m. . | Percentage of PWM control ± s.e.m. . | ||
---|---|---|---|---|
AM06† | 32.3±5.7 | 40.6±7.2 | ||
AM10† | 54.3±3.5 | 68.2±4.4 | ||
AM14† | 33.0±6.4 | 41.5±8.1 | ||
AM20* | 72.3±4.7 | 90.9±5.9 | ||
AM30 | 49.3±4.5 | 61.9±5.7 | ||
UG07† | 55.0±4.6 | 69.2±5.8 | ||
UG15† | 32.5±2.1 | 40.9±2.6 | ||
UG26 | 61.8±2.6 | 77.7±3.3 | ||
EL08† | 61.0±5.1 | 76.7±6.4 | ||
EL12† | 19.0±2.9 | 23.9±3.6 | ||
EL17*,† | 48.3±2.8 | 60.7±3.5 | ||
EL23 | 47.5±2.7 | 59.7±3.4 | ||
EL28 | 44.3±4.6 | 55.7±5.8 | ||
AFT024 | 35.8±2.8 | 45.0±3.5 | ||
FBMD-1 | 37.5±2.8 | 47.2±3.5 | ||
S17 | 46.8±2.1 | 58.8±2.6 | ||
Four experiments were carried out. *Stromal lines derived from E10 tissue. All other stromal lines are derived from E11 tissues. †Stromal lines derived from BL1b transgenic embryos. All other stromal lines are derived from tsA58 transgenic embryos. Culture supernatants were collected from non-irradiated cells. |